Compare · CCEL vs NIVF
CCEL vs NIVF
Side-by-side comparison of Cryo-Cell International Inc. (CCEL) and NewGenIvf Group Limited (NIVF): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CCEL and NIVF operate in Misc Health and Biotechnology Services (Health Care), so they compete in similar markets.
- CCEL is the larger of the two at $83.3M, about 268.7x NIVF ($310,083).
- Over the past year, CCEL is down 36.1% and NIVF is down 99.9% - CCEL leads by 63.8 points.
- NIVF has been more active in the news (16 items in the past 4 weeks vs 1 for CCEL).
- Company
- Cryo-Cell International Inc.
- NewGenIvf Group Limited
- Price
- $3.41-1.16%
- $0.56-7.80%
- Market cap
- $83.3M
- $310,083
- 1M return
- -3.67%
- -55.73%
- 1Y return
- -36.14%
- -99.90%
- Industry
- Misc Health and Biotechnology Services
- Misc Health and Biotechnology Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2022
- News (4w)
- 1
- 16
- Recent ratings
- 0
- 0
Cryo-Cell International Inc.
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, kidney, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Latest CCEL
- VP Finance, CFO Taymans Jill M exercised 7,500 shares at a strike of $3.10, increasing direct ownership by 17% to 52,896 units (SEC Form 4)
- Cryo-Cell International Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits
- Cryo-Cell Receives Acceptance of Compliance Plan From NYSE American
- Cryo-Cell International Receives FACT Re-accreditation, Setting the Longest Independently Validated Quality Track Record Among U.S. Private Cord Blood Banks
- SEC Form 10-Q filed by Cryo-Cell International Inc.
- Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2026 Financial Results
- Cryo-Cell International Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits
- Cryo-Cell Receives NYSE American Continued Listing Notice
- SEC Form 10-K filed by Cryo-Cell International Inc.
- Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2025
Latest NIVF
- Large owner Hrt Financial Lp sold $50,722 worth of shares (64,945 units at $0.78), decreasing direct ownership by 78% to 18,134 units (SEC Form 4)
- Director Siu Wing Fung Alfred exercised 56,851 units of Class B Ordinary Shares at a strike of $0.00, increasing direct ownership by 189,503% to 56,881 units (SEC Form 4)
- Director Fong Hei Yue Tina exercised 56,851 units of Class B Ordinary Shares at a strike of $0.00, increasing direct ownership by 145,772% to 56,890 units (SEC Form 4)
- Large owner Hrt Financial Lp bought $32,000 worth of shares (34,756 units at $0.92), increasing direct ownership by 72% to 83,079 units (SEC Form 4)
- New insider Hrt Financial Lp claimed ownership of 71,341 shares (SEC Form 3)
- K25.ai Secures US$6 Million Strategic Investment from Nasdaq-Listed NewGen at US$100 Million Valuation; Co-Founders to Join Board and Lead Digital Asset Treasury Strategy
- SEC Form 6-K filed by NewGenIvf Group Limited
- NewGen Doubles Down on K25.ai with Additional US$4 Million Stake and Adopts Digital Asset Treasury Strategy
- Large owner Hrt Financial Lp sold $68,254 worth of shares (85,317 units at $0.80), decreasing direct ownership by 61% to 54,561 units (SEC Form 4)
- SEC Form 6-K filed by NewGenIvf Group Limited